For Dovato PI Please click here
For more information, please refer to the prescribing information or contact GSK: P.O Box 55850, Jeddah, 21544,
Kingdom of Saudi Arabia. Telephone: +966 12 653 6666 or via gcc.medinfo@gsk.com
To report Adverse Event/s associated with the use of GSK product/s, please contact us via saudi.safety@gsk.com
To report Quality related product complaint/s associated with the use of GSK product/s, please contact us via Gulf-KSA.Product-Complaints@gsk.com
This email is intended for Saudi Arabia healthcare professionals only. You are receiving this email as we have your details as a health care professional. If you do not wish to receive these emails in future or unsubscribe, E-mail programs can consider these messages as junk mail and may automatically put them in your bulk or junk folder. To ensure the e-mails you’ve requested are delivered to your inbox, add our e-mail address to your address book. Please do not reply to this message. These emails are not monitored and do not accept replies. About your privacy: GSK may monitor our technology tools and services (including email, phone, and other communications sent to and from GSK) in order to maintain the security of systems, and to protect our staff, customers and business partners from cyber threats and loss of information. Examples of these monitoring activities include checks for offensive materials, viruses and other malignant code, and unauthorized or unlawful activity. GSK monitoring is conducted with appropriate confidentiality controls and in accordance with local laws. You can learn about the information that we may process about you, and how we use your information, click here. You can also view our terms of use.
To Unsubscribe click here
© 2024 GlaxoSmithKline group of companies.
All rights reserved. GlaxoSmithKline Limited, Registered in Saudi Arabia.
PM-SA-DLL-EML-240007
Preparation Date: April 2024